Skip to main content
Equibles

GLAXF · GSK plc

Track GLAXF — free

Use GLAXF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GLAXF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$23.55 At close · Oct 5
Rebalance outlook locked
Market Cap
$98.62B
Shares
2.00B
Volume · Oct 5 2531 Avg daily vol (3M) 1024

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$23.55 Open$22.50 Day$22.50–23.55 52W close$20.97–31.48 Avg vol 30d1K Last earningsFeb 3, 2027 DataJan 2020–Oct 2026

Up next

Next earnings call
Oct 28, 2026 Scheduled · in 3 wks
Q1 2026 earnings call transcript
call held Apr 29, 2026

Guidance & track record

Latest guidance · from the Earnings Call filed Dec 31, 2025
Core operating profit growth · 2026 Non-GAAP 7% – 9%
Core earnings per share growth · 2026 Non-GAAP 7% – 9%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $25 › 200d $24 — 50d above 200d
Institutional flow Distributing
12 of 1,057 funds reported for Sep 30 · net -12.4K sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
No short-interest data
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
1,057 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $21 Now $24 · 25% Range high $31
vs 200-day avg -2% vs 50-day avg -7%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - General — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
GLAXF
GSK plc
this stock
$98.62B -4.3% — — —
LLY
ELI LILLY & Co
 $1.11T +6.4% +44.7% 39.7 0.8%
JNJ
Johnson & Johnson
 $653.61B +22.2% +6.0% 31.5 0.9%
ABBV
AbbVie Inc.
 $466.80B +16.3% +8.6% 74.6 1.1%
MRK
Merck & Co., Inc.
 $367.07B +32.6% +1.3% 119.0 1.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
1,056
% held
17.5%
Reported
12 of 1,057
Top holder
FMR LLC
Held Float
View
Short & Settlement
Fails to Deliver
FTD shares
999
Value
$50.8K
As of
Sep 4, 2026
View
Smart Money
Congressional Trades Sell
Member
Lisa McClain
Amount
$1.0K–$15.0K
Traded
Oct 31, 2025
View
Filings
SEC Filings
Latest
6-K
Filed
Oct 1, 2026
This year
205
View
Proposed Sales
Value
$2.3M
Shares
44.4K
Filed
Aug 20, 2026
View
Earnings & Events
Webcasts Upcoming
Next webcast
Oct 28, 2026
Last webcast
Sep 23, 2026
View
Investor Relations
Upcoming events
2
View

Performance

5D 20D 120D MTD YTD
GLAXF -5.6% -3.1% +0.0% -1.9% -4.3%
SPY +1.2% +0.6% +11.6% +1.6% +13.6%
vs SPY -6.8% -3.7% -11.5% -3.5% -17.9%
Key facts CIK 1131399 CUSIP 37733W204 Visit website Investor relations